Dr Reddys Laboratories Ltd Share Price Today - Live Blog for March 31, 2026

The share price of Dr Reddys Laboratories Ltd has plummeted by -2.09%, signalling a challenging period. Currently trading at 1254.90, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The stock of Dr Reddys Laboratories Ltd suffered a -2.09% decline, and it currently trades at 1254.90 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The share price of Dr Reddys Laboratories Ltd has plummeted by -2.09%, signalling a challenging period. Currently trading at 1254.90, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd observed a -2.09% decrease in its share price, a situation that merits attention. As of now, it's actively trading at 1254.90. The stock has a PE ratio of 18.9600, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -2.09% in its share price, and it currently trades at 1254.90 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has fallen by -2.09%, a situation worth noting. At present, the stock is trading at 1254.90. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.9600, while the industry PE ratio is 31.4443.

Dr Reddys Laboratories Ltd's share price has fallen by -2.09%, presenting both challenges and opportunities for investors. As of now, it's trading at 1254.90, and market participants are assessing the implications. The stock has a PE ratio of 18.9600, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

The stock of Dr Reddys Laboratories Ltd has experienced a -2.09% drop, and it's now trading at 1254.90 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

With a -2.09% decrease, Dr Reddys Laboratories Ltd's share price is now at 1254.90. The stock is currently trading at a PE of 18.9600, while the industry PE is 31.4443, prompting investors to assess its value proposition.

After a -2.09% decline, Dr Reddys Laboratories Ltd shares are now trading at 1254.90. The stock has a PE ratio of 18.9600, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

With a -2.09% decrease, Dr Reddys Laboratories Ltd's share price is currently at 1254.90. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.9600, while the industry PE is 31.4443.